Assessing fluid status in hospitalized patients using ultrasound
HOspitalized Patients and Clinical flUid Status, Assessment Using Point Of Care UltraSound
This study tests whether using ultrasound to look at a specific vein can help doctors better understand the fluid levels in hospitalized patients after they've been admitted for at least a day.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Flevoziekenhuis Academic / other |
| Locations | 1 site (Almere Stad) |
| Trial ID | NCT06379347 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the diagnostic utility of point-of-care ultrasound (POCUS) of the inferior vena cava (IVC) in hospitalized patients. Conducted by trained physicians, the study aims to standardize the methodology for assessing volume status in patients admitted to the general ward for at least 24 hours. Data will be collected at admission and after 48 hours, focusing on the IVC's diameter during respiratory cycles to determine whether patients are hypovolemic or hypervolemic. The study seeks to fill the gap in existing research regarding the use of IVC ultrasound in sub-acute settings.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients over 18 years old with a clinical indication for an IVC ultrasound.
Not a fit: Patients using vasopressors or requiring invasive/non-invasive ventilation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance clinical decision-making regarding fluid management in hospitalized patients.
How similar studies have performed: While previous studies have focused on critically ill populations, this approach in a sub-acute setting is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient is over 18 years old. * Patient has a clinical indication for making a IVC ultrasound. * Patient is admitted until at least 24 hours after the first ultrasound. Exclusion Criteria: * Patients who are using vasopressors at the time of the ultrasound. * Patients who require invasive or non-invasive (optiflow, CPAP, BPAP) ventilation.
Where this trial is running
Almere Stad
- Flevoziekenhuis — Almere Stad, Netherlands (Recruiting)
Study contacts
- Principal investigator: Koen de Heer, MD PhD — Flevoziekenhuis
- Study coordinator: Koen de Heer, MD PhD
- Email: psp@flevoziekenhuis.nl
- Phone: +31 36 8688888
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.